NLRP3 Inflammasome Inhibitors for Antiepileptogenic Drug Discovery and DevelopmentInamul Haque, Vikas Singh, Mukut Sharma et al.|Preprints.org|2024Cited by 2
Developing Novel Therapeutic Agents Targeting NLRP3 Inflammasome Inhibition and Oxidative Stress Mitigation for Epilepsy and Neurodegenerative Disorders (P9-9.005)Vikas Singh, Mukut Sharma, Pritam Thapa et al.|Neurology|2025Cited by 2